AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in a clinical study of AtriCure’s AtriClip Left Atrial Appendage Exclusion System.

Fractional flow reserve (FFR) is considered the gold standard in determining the hemodynamic significance of coronary lesions, but its use remains low. Two new technologies may help increase its use.

The American College of Cardiology (ACC) and the American Heart Association (AHA) released a clinical practice guideline to help primary care clinicians better identify adults who may be at high risk for developing atherosclerotic cardiovascular disease, stroke and who thus may benefit from lifestyle changes or drug therapy to help prevent it.

The tiny device, about the size of the head of a pen, can be delivered via a delivery catheter through the venous system and placed directly into the myocardium of the right ventricle.

As health IT leaders make their way to New York for the New York eHealth Collaborative (NYeC) Digital Health Conference, Practice Fusion, the nation's largest healthcare platform, is looking at the key healthcare trend from 2013 and predicts what they might mean looking forward.